|
|
???tair.name??? >
???browser.page.title.author???
|
"fleishaker d"???jsp.browse.items-by-author.description???
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 中山醫學大學 |
2021 |
EFFECT OF TOFACITINIB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM A PHASE 3 TRIAL
|
Navarro-Compan, V; Wei, JCC; Van den Bosch, F; Magrey, M; Wang, L; Fleishaker, D; Cappelleri, JC; Wang, C; Wu, J; Dina, O; Fallon, L; Strand, V |
| 中山醫學大學 |
2021 |
Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
|
Nash, P; Mease, PJ; Fleishaker, D; Wu, J; Coates, LC; Behrens, F; Gladman, DD; Kivitz, AJ; Wei, JC; Shirinsky, I; Menon, S; Romero, AB; Fallon, L; Hsu, MA; Wang, CS; Kanik, KS |
| 中山醫學大學 |
2020 |
TOFACITINIB AS MONOTHERAPY FOLLOWING METHOTREXATE WITHDRAWAL IN PATIENTS WITH PSORIATIC ARTHRITIS PREVIOUSLY TREATED WITH OPEN-LABEL TOFACITINIB plus METHOTREXATE: A RANDOMISED, PLACEBO-CONTROLLED SUBSTUDY OF OPAL BALANCE
|
Nash, P; Coates, LC; Mease, PJ; Kivitz, A; Gladman, DD; Behrens, F; Wei, JCC; Fleishaker, D; Wu, J; Wang, C; Romero, AB; Fallon, L; Hsu, MA; Kanik, K |
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
